FDA product code QRX: Continuous Glucose Monitor Informed Insulin Dose Calculator

QRX is the FDA product code for continuous glucose monitor informed insulin dose calculator. It is a Class II device, regulated under 21 CFR 862.1358 and reviewed by the Clinical Chemistry panel. FDA has cleared 6 510(k) submissions under QRX, 6 in the last five years, from 4 different applicants. The average 510(k) review took 197 days (median 181); 159 days on average over the last three years. FDA has posted 2 recalls for QRX devices, 2 initiated in the last five years.

Definition

A continuous glucose monitor (CGM)-informed insulin dose calculator is a software device that calculates suggested insulin doses based on CGM values and/or other relevant information.

Classification

FieldValue
Device nameContinuous Glucose Monitor Informed Insulin Dose Calculator
Device classClass II
Regulation21 CFR 862.1358
Review panelCH — Clinical Chemistry
Medical specialtyClinical Chemistry
Premarket route510(k)

510(k) clearances per year for QRX

YearClearancesAvg. review days
20222212
20232220
2025175
20261243

Compare with all 510(k) review times · Search every QRX clearance

Top QRX applicants

ApplicantClearancesLatest
Insulet Corporation32023-10-18
DreaMed Diabetes, Ltd.12026-09-08
Dexcom, Inc.12025-11-18
Welldoc, Inc.12023-08-11

Most recent QRX clearances

510(k)ApplicantDeviceDecision dateReview days
K260062DreaMed Diabetes, Ltd.MODI System2026-09-08243
K252818Dexcom, Inc.Dexcom Smart Basal2025-11-1875
K231824Insulet CorporationSmartBolus Calculator2023-10-18119
K222888Welldoc, Inc.BlueStar CGM insulin dose calculator2023-08-11322
K222239Insulet CorporationSmartBolus Calculator2022-08-1924

Recalls for QRX devices

2 product recalls in 2 recall events; 2 initiated in the last five years and 2 still open. Most recent: 2025-09-11.

YearRecalls
20252

Frequently asked questions

What is FDA product code QRX?

QRX is the FDA product code for continuous glucose monitor informed insulin dose calculator. It is a Class II device, regulated under 21 CFR 862.1358 and reviewed by the Clinical Chemistry panel.

What device class is QRX?

Class II, regulation 21 CFR 862.1358. Typical premarket route: 510(k).

How long does a 510(k) take for product code QRX?

Across 6 cleared submissions the average was 197 days from receipt to decision (median 181).

Which companies have the most QRX clearances?

Insulet Corporation (3); DreaMed Diabetes, Ltd. (1); Dexcom, Inc. (1); Welldoc, Inc. (1).

Have QRX devices been recalled?

Yes: 2 product recalls across 2 recall events; the most recent began 2025-09-11.

Next steps

Compiled by Caduvo from public U.S. FDA records. Applicant names are shown as FDA records them. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA. Not regulatory advice. Report an error. Data and corrections policy.

All Clinical Chemistry product codes · FDA product code lookup · 510(k) database search · 510(k) review times